ArticleFrontiers in oncology2020

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer.

Wenxian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.